Secor Capital Advisors’s Emergent Biosolutions EBS Stock Holding History

Secor Capital Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-36,471	Closed	-$1.92M	–	534
2018 Q1	$1.92M	Buy	+36,471	New	+$1.82M	0.16%	214
2017 Q3	–	Sell	-45,221	Closed	-$1.53M	–	462
2017 Q2	$1.53M	Buy	+45,221	New	+$1.4M	0.14%	212
2016 Q4	–	Sell	-64,797	Closed	-$2.04M	–	523
2016 Q3	$2.04M	Buy	64,797 +10,906	+20%	+$317K	0.22%	140
2016 Q2	$1.43M	Buy	+53,891	New	+$2.11M	0.18%	184
2016 Q1	–	Sell	-11,108	Closed	-$444K	–	645
2015 Q4	$444K	Buy	+11,108	New	+$387K	0.13%	272
2015 Q2	–	Sell	-12,430	Closed	-$357K	–	453
2015 Q1	$357K	Buy	+12,430	New	+$356K	0.14%	270
2014 Q2	–	Sell	-14,831	Closed	-$375K	–	256
2014 Q1	$375K	Sell	14,831 -306	-2%	-$7.73K	0.18%	205
2013 Q4	$348K	Buy	+15,137	New	+$316K	0.14%	245

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Secor Capital Advisors's EBS Position: Q2 2018 in Review

Secor Capital Advisors sold out of Emergent Biosolutions (EBS) in Q2 2018, closing a stake of 36,471 shares — an estimated $1.92M sold.

Secor Capital Advisors first reported a position in EBS in Q4 2013 and held it in 8 quarters. The position peaked at $2.04M in Q3 2016. 263 funds tracked by Wall St. Rank hold EBS as of Q2 2018.

Secor Capital Advisors reported no remaining Emergent Biosolutions position as of Q2 2018 after selling out during the quarter.
Secor Capital Advisors sold 36,471 Emergent Biosolutions shares in Q2 2018, an estimated $1.92M.
Secor Capital Advisors first reported a position in Emergent Biosolutions in Q4 2013 and held it in 8 quarters.
Secor Capital Advisors's Emergent Biosolutions position peaked at $2.04M in Q3 2016.
263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2018.

Based on Secor Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.